Search for: "MedImmune, Inc. v. Genentech, Inc" Results 1 - 20 of 156
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Feb 2022, 6:12 pm by Dennis Crouch
  This question ties the case directly to MedImmune, Inc. v. [read post]
20 Dec 2021, 8:42 am by Dennis Crouch
Hazeltine Research, Inc., 401 U.S. 321 (1971) (antitrust – patent pools – waiver of defenses); MedImmune, Inc. v. [read post]
14 Dec 2021, 9:57 am by Dennis Crouch
  As you can see, this question attempts to tie the case directly to MedImmune, Inc. v. [read post]
26 Oct 2021, 6:53 am by Unknown
Did the court of appeals err in adopting a new and inflexible rule,contrary to normal standing rules and this Court’s decision in MedImmune, Inc. [read post]
7 Jun 2021, 6:36 am by Dennis Crouch
Genentech, Inc., 549 U.S. 118 (2007). [read post]
19 May 2021, 10:40 am by Dennis Crouch
Genentech, Inc., 549 U.S. 118 (2007); Cardinal Chem. [read post]
2 Jun 2020, 1:50 pm by Dennis Crouch
  Later, in MedImmune, Inc. v. [read post]
24 May 2018, 8:53 pm by Patent Docs
Noonan -- Ever since the Supreme Court loosened the reins on declaratory judgment actions in patent cases twelve years ago, in MedImmune v. [read post]
8 Sep 2016, 11:29 am by Dennis Crouch
The leading precedent actual-controversy precedent for patent cases is the Supreme Court’s 2007 decision in MedImmune, Inc. v. [read post]